All stock lists
Mastec Inc (New York Stock Exchange:MTZ)
US · Delayed Price · Currency is USD
Industrials · Engineering & Construction
167.61-30.49 (-15.39%)
Market cap
$13.5B
Insider Score
Health Score
Analyst consensus
Listed since
Feb 21, 1973
Website
Insider Score
––Not scored
MTZ Insider Score
Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.
MTZ analyst forecast
MTZ analyst consensus
Moderate Buy11 ratings
Buy 11 Hold 0 Sell 0
Based on each firm’s most recent rating in the last 3 months — one vote per firm, so a desk that reiterates weekly does not count three times.
MTZ 12-month price target
$302.50+80.5% upsideaverage of 4 firms
$353.00High
$270.00Low
MTZ ratings mix, last 12 months
Buy Hold Sell
Best analysts covering MTZ
- Stifel100%success rate · +91.8% avg return · 12 calls
- DA Davidson100%success rate · +41.1% avg return · 7 calls
- Guggenheim100%success rate · +178.1% avg return · 2 calls
- Roth Capital100%success rate · +4.1% avg return · 1 call
Measured by us from each firm’s own rating dates and this stock’s split- and dividend-adjusted closes. How we calculate this.
MTZ analyst ratings
| Firm | Price target | Action | ||||
|---|---|---|---|---|---|---|
| Jefferies | — | $353.00 | +78.2% | — | 2026-11-04 | |
| — | TD Cowen | Buy | — | — | Reiterated | 2026-11-02 |
| Cantor Fitzgerald | Overweight | $270.00 | +37.4% | Reiterated | 2026-11-02 | |
| — | Truist Securities | Buy | — | — | Reiterated | 2026-11-02 |
| — | Roth Capital | Buy | — | — | Reiterated | 2026-11-02 |
| — | Citigroup | Buy | — | — | Reiterated | 2026-10-23 |
| Goldman Sachs | — | $274.00 | +51.4% | — | 2026-10-22 | |
| — | Barclays | Overweight | — | — | Reiterated | 2026-10-19 |
| — | JP Morgan | Overweight | — | — | Reiterated | 2026-10-19 |
| — | Keybanc | Overweight | — | — | Reiterated | 2026-10-15 |
| Cantor Fitzgerald | — | $348.00 | +63.6% | — | 2026-10-12 | |
| — | Stifel | Buy | — | — | Reiterated | 2026-10-08 |
| — | Truist Securities | Buy | — | — | Reiterated | 2026-10-05 |
| — | TD Cowen | Buy | — | — | Reiterated | 2026-10-05 |
| Piper Sandler | Overweight | $313.00 | +47.1% | Reiterated | 2026-09-28 | |
| — | Goldman Sachs | Buy | — | — | Reiterated | 2026-08-12 |
| — | Mizuho | Outperform | — | — | Reiterated | 2026-08-04 |
| — | UBS | Buy | — | — | Reiterated | 2026-08-04 |
| — | Truist Securities | Buy | — | — | Reiterated | 2026-08-03 |
| — | Keybanc | Overweight | — | — | Reiterated | 2026-08-03 |
| — | Baird | Outperform | — | — | Reiterated | 2026-08-03 |
| — | Citigroup | Buy | — | — | Reiterated | 2026-08-03 |
| — | TD Cowen | Buy | — | — | Reiterated | 2026-08-03 |
| — | Guggenheim | Buy | — | — | Reiterated | 2026-07-22 |
| — | TD Cowen | Buy | — | — | Reiterated | 2026-07-13 |
| — | Baird | Outperform | — | — | Reiterated | 2026-07-09 |
| — | Cantor Fitzgerald | Overweight | — | — | Reiterated | 2026-07-09 |
| — | Mizuho | Outperform | — | — | Reiterated | 2026-07-08 |
| — | Truist Securities | Buy | — | — | Reiterated | 2026-07-02 |
| — | Guggenheim | Buy | — | — | Upgraded | 2026-05-13 |
| — | JP Morgan | Overweight | — | — | Reiterated | 2026-05-13 |
| — | Keybanc | Overweight | — | — | Reiterated | 2026-05-13 |
| — | Cantor Fitzgerald | Overweight | — | — | Reiterated | 2026-05-11 |
| — | Mizuho | Outperform | — | — | Reiterated | 2026-05-05 |
| — | Keybanc | Overweight | — | — | Reiterated | 2026-05-04 |
| — | Truist Securities | Buy | — | — | Reiterated | 2026-05-04 |
| — | TD Cowen | Buy | — | — | Reiterated | 2026-05-04 |
| — | Citigroup | Buy | — | — | Reiterated | 2026-05-04 |
| — | Goldman Sachs | Buy | — | — | Reiterated | 2026-05-04 |
| — | Baird | Outperform | — | — | Reiterated | 2026-05-04 |
| — | UBS | Buy | — | — | Reiterated | 2026-05-01 |
| — | Citigroup | Buy | — | — | Reiterated | 2026-04-27 |
| — | Truist Securities | Buy | — | — | Reiterated | 2026-04-20 |
| — | Stifel | Buy | — | — | Reiterated | 2026-04-17 |
| — | Clear Street | Buy | — | — | Reiterated | 2026-04-17 |
| — | JP Morgan | Overweight | — | — | Reiterated | 2026-04-16 |
| — | UBS | Buy | — | — | Reiterated | 2026-04-13 |
| — | Barclays | Overweight | — | — | Reiterated | 2026-03-31 |
| — | Jefferies | Buy | — | — | Reiterated | 2026-03-13 |
| — | Mizuho | Outperform | — | — | Reiterated | 2026-03-03 |
| — | Baird | Outperform | — | — | Reiterated | 2026-03-02 |
| — | Truist Securities | Buy | — | — | Reiterated | 2026-03-02 |
| — | Citigroup | Buy | — | — | Reiterated | 2026-03-02 |
| — | Keybanc | Overweight | — | — | Reiterated | 2026-03-02 |
| — | DA Davidson | Buy | — | — | Reiterated | 2026-03-02 |
| — | Cantor Fitzgerald | Overweight | — | — | Reiterated | 2026-03-02 |
| — | Citigroup | Buy | — | — | Reiterated | 2026-01-26 |
| — | Barclays | Overweight | — | — | Reiterated | 2026-01-23 |
| — | Truist Securities | Buy | — | — | Reiterated | 2025-12-18 |
| — | Stifel | Buy | — | — | Reiterated | 2025-12-16 |
MTZ earnings vs. estimates
| Quarter | EPS est. | EPS actual | Revenue est. | Revenue actual |
|---|---|---|---|---|
| 2026-02-26 | 1.95 | 2.07 | $3.72B | $3.94B |
| 2026-04-30 | 0.99 | 1.39 | $3.47B | $3.83B |
| 2026-07-30 | 2.23 | 2.22 | $4.30B | $4.37B |
| 2026-10-29 | 2.95 | 2.96 | $4.94B | $5.15B |
| 2027-02-25Upcoming | 2.55 | — | $4.97B | — |
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.